Skip to main content
SpringerLink
Log in
Book cover

Cornea and External Eye Disease pp 1–20Cite as

Autologous Serum Eyedrops for Ocular Surface Disorders

  • Chapter

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alvarado Valero MC, Martinez Toldos JJ, Borras Blasco J, Alminana Alminana A, Perez Ramos JM (2004) [Treatment of persistent epithelial defects using autologous serum application.]. Arch Soc Esp Oftalmol 79(11):537–542

    CAS  PubMed  Google Scholar 

  2. Chiou AG, Florakis GJ, Kazim M (1998) Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction. Surv Ophthalmol 43(1):19–46

    CAS  PubMed  Google Scholar 

  3. Ciba-Geigy (1978) Wissenschaftliche Tabellen Geigy. Ciba-Geigy, Basel

    Google Scholar 

  4. del Castillo JM, de la Casa JM, Sardina RC, Fernandez RM, Feijoo JG, Gomez AC et al. (2002) Treatment of recurrent corneal erosions using autologous serum. Cornea 21(8):781–783

    PubMed  Google Scholar 

  5. Dugrillon A, Lauber S, Nguyen XD, Klueter H (2002) Platelets applied to wounds and in tissue regeneration: induction of proliferation apoptosis by platelet membranes. In: Mempel W, Schramm W (eds) Infusion therapy and transfusion medicine. Kluwer Academic/Plenum, Amsterdam, pp 70–71

    Google Scholar 

  6. Eberle J, Habermann J, Gurtler LG (2000) HIV-1 infection transmitted by serum droplets into the eye: a case report. AIDS 14(2):206–207

    CAS  PubMed  Google Scholar 

  7. Ebner S, You L, Voelcker HE, Kruse FE (2001) Effect of autologous serum on the healing of noninfectious corneal ulcers and expression of growth factor receptors in the cornea. Ophthalmologe 98:S27

    Google Scholar 

  8. Ferreira de Souza R, Kruse FE, Seitz B (2001) [Autologous serum for otherwise therapy resistant corneal epithelial defects — prospective report on the first 70 eyes]. Klin Monatsbl Augenheilkd 218(11):720–726

    Article  CAS  PubMed  Google Scholar 

  9. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE (1984) Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 27(4):459–461

    CAS  PubMed  Google Scholar 

  10. Fullard RJ, Tucker DL (1991) Changes in human tear protein levels with progressively increasing stimulus. Invest Ophthalmol Vis Sci 32:2290–2301

    CAS  PubMed  Google Scholar 

  11. Garcia Jimenez V, Veiga Villaverde B, Baamonde Arbaiza B, Cahue Carpintero I, Celemin Vinuela M, Simo Martinez R (2003) [The elaboration, use and evaluation of eye-drops with autologous serum in corneal lesions]. Farm Hosp 27(1):21–25

    CAS  PubMed  Google Scholar 

  12. Geerling G, Honnicke K, Schroder C, Framme C, Sieg P, Lauer I et al. (1999) Quality of salivary tears following autologous submandibular gland transplantation for severe dry eye. Graefes Arch Clin Exp Ophthalmol 237(7):546–553

    Article  CAS  PubMed  Google Scholar 

  13. Geerling G, Daniels JT, Dart JK, Cree IA, Khaw PT (2001) Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 42(5):948–956

    CAS  PubMed  Google Scholar 

  14. Geerling G, Hartwig D (2002) [Autologous serum eye-drops for ocular surface disorders. A literature review and recommendations for their application]. Ophthalmologe 99(12):949–959

    Article  CAS  PubMed  Google Scholar 

  15. Gordon JF et al. (1995) Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Am J Ophthalmol 119:281–287

    CAS  PubMed  Google Scholar 

  16. Goto E, Shimmura S, Shimazaki J, Tsubota K (2001) Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 20(8):807–810

    Article  CAS  PubMed  Google Scholar 

  17. Harloff S, Hartwig D, Dibbelt L, Wedel T, Geerling G (2002) Korneale epitheliotrophe Kapazität von Serum immunsuppressierter verglichen mit dem gesunden Spender. Ophthalmologe 100:S152

    Google Scholar 

  18. Hartwig D, Harloff S, Liu L, Schlenke P, Wedel T, Geerling G (2004) Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects? Transfusion 44(12):1724–1731

    Article  CAS  PubMed  Google Scholar 

  19. Herminghaus P, Geerling G, Hartwig D, Wedel T, Dibbelt L (2004) [Epitheliotrophic capacity of serum and plasma eyedrops: Influence of centrifugation]. Ophthalmologe 101(10):998–1005

    CAS  PubMed  Google Scholar 

  20. Joh T, Itoh M, Katsumi K, Yokoyama Y, Takeuchi T, Kato T et al. (1986) Physiological concentrations of human epidermal growth factor in biological fluids: use of a sensitive enzyme immunoassay. Clin Chim Acta 158(1):81–90

    Article  CAS  PubMed  Google Scholar 

  21. Jones L, Senchyna M, Glasier MA, Schickler J, Forbes I, Louie D et al. (2003) Lysozyme and lipid deposition on silicone hydrogel contact lens materials. Eye Contact Lens 29(1 Suppl):S75–79; discussion S83–84, S192–194

    Google Scholar 

  22. Kao WWY, Kao CWC, Kaufman AH, Kombrinck KW, Converse RL, Good WV et al. (1998) Healing of corneal epithelial defects in plasminogen-and fibrinogen-deficient mice. Invest Ophthalmol Vis Sci 39:502–508

    CAS  PubMed  Google Scholar 

  23. Lagnado R, King AJ, Donald F, Dua HS (2004) A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 88(4):464–465

    Article  CAS  PubMed  Google Scholar 

  24. Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G (2005) An optimized protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 243:706–714

    Article  CAS  PubMed  Google Scholar 

  25. Lopez Bernal D, Ubels JL (1993) Artificial tear composition and promotion of recovery of the damaged corneal epithelium. Cornea 12(2):115–120

    Google Scholar 

  26. Macaluso D, Feldman S (1997) Pathogenesis of sterile corneal erosions and ulcerations. In: Krachmer J, Mannis M, Holland E (eds) Cornea. Mosby, St Louis, pp 204–209

    Google Scholar 

  27. Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R et al. (2004) Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111(6):1115–1120

    Article  PubMed  Google Scholar 

  28. McDonnell PJ, Schanzlin DJ, Rao NA (1988) Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol 106:1423–1425

    CAS  PubMed  Google Scholar 

  29. Nelson JD, Gordon JF (1992) Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group. Am J Ophthalmol 114(4):441–447

    CAS  PubMed  Google Scholar 

  30. Ng V, Cho P, Mak S, Lee A (2000) Variability of tear protein levels in normal young adults: between-day variation. Graefes Arch Clin Exp Ophthalmol 238:892–899

    CAS  PubMed  Google Scholar 

  31. Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR et al. (2004) Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 88(5):647–652

    Article  CAS  PubMed  Google Scholar 

  32. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R et al. (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31(7):579–583

    Article  CAS  PubMed  Google Scholar 

  33. Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT (2001) Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 85(10):1188–1197

    Article  CAS  PubMed  Google Scholar 

  34. Rocha EM, Pelegrino FS, de Paiva CS, Vigorito AC, de Souza CA (2000) GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 25(10):1101–1103

    Article  CAS  PubMed  Google Scholar 

  35. Sauer R, Bluthner K, Seitz B (2004) [Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects]. Ophthalmologe 101(7):705–709

    Article  CAS  PubMed  Google Scholar 

  36. Scardovi C, De Felice GP, Gazzaniga A (1993) Epidermal growth factor in the topical treatment of traumatic corneal ulcers. Ophthalmologica 206: 119–124

    CAS  PubMed  Google Scholar 

  37. Shimmura S, Ueno R, Matsumoto Y, Goto E, Higuchi A, Shimazaki J et al. (2003) Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol 87(10):1279–1283

    Article  CAS  PubMed  Google Scholar 

  38. Sitaramamma T, Shivaji S, Rao GN (1998) Effect of storage on protein concentration of tear samples. Curr Eye Res 17(10):1027–1035

    Article  CAS  PubMed  Google Scholar 

  39. Takamura E, Shiozaki K, Hata H, Yukari J, Hori S (2002) Efficacy of autologous serum treatment in patients with severe dry eye. In: Sullivan DA (ed) Lacrimal gland, tear film, and dry eye syndromes 3. Kluwer Academic/Plenum, New York, pp 1247–1250

    Google Scholar 

  40. Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ et al. (2001) Controlled study of the use of autologous serum in dry eye patients. Cornea 20(8):802–806

    Article  CAS  PubMed  Google Scholar 

  41. Thomas L (1998) Labor und Diagnose, 5th edn. TH-Books, Frankfurt/Main, p 1494

    Google Scholar 

  42. Tighe BJ, Jones L, Evans K, Franklin V (1998) Patient-dependent and material-dependent factors in contact lens deposition processes. Adv Exp Med Biol 438:745–751

    CAS  PubMed  Google Scholar 

  43. Torsteinsdóttir L, Hakansson L, Hällgren R, Gudbjörnsson B, Arvidson NG, Venge P (1999) Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. Rheumatology 38:1249–1254

    PubMed  Google Scholar 

  44. Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M et al. (1996) Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome [see comments]. Am J Ophthalmol 122(1):38–52

    CAS  PubMed  Google Scholar 

  45. Tsubota K, Goto E, Fujita H, Ono M, Inouc H, Saito I et al. (1999) Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol 83:390–395

    CAS  PubMed  Google Scholar 

  46. Tsubota K, Goto E, Shimmura S et al. (1999) Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106(10):1984–1989

    Article  CAS  PubMed  Google Scholar 

  47. Tsubota K, Shimazaki J (1999) Surgical treatment of children blinded by Stevens-Johnson Syndrome. Am J Ophthalmol 128:573–581

    Article  CAS  PubMed  Google Scholar 

  48. Tsubota K, Goto E, Shimmura S, Shimazaki J (1999) Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106(10):1984–1989

    Article  CAS  PubMed  Google Scholar 

  49. Ubels J, Williams K, Lopez Bernal D, Edelhauser H (1994) Evaluation of effects of a physiologic artificial tear on the corneal epithelial barrier: electrical resistance and carboxyfluorescein permeability. In: Sullivan DA (ed) Lacrimal gland, tear film and dry eye syndromes. Plenum Press, New York, pp 441–452

    Google Scholar 

  50. Vajpayee RB, Mukerji N, Tandon R, Sharma N, Pandey RM, Biswas NR et al. (2003) Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 87(11): 1312–1316

    Article  CAS  PubMed  Google Scholar 

  51. Yokoi N, Komuro A, Nishida K, Kinoshita S (1997) Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye [see comments]. Br J Ophthalmol 81(7):533–536

    CAS  PubMed  Google Scholar 

  52. Young AL, Cheng AC, Ng HK, Cheng LL, Leung GY, Lam DS (2004) The use of autologous serum tears in persistent corneal epithelial defects. Eye 18(6):609–614

    Article  CAS  PubMed  Google Scholar 

  53. Geerling G, Mac Lennan S, Hartwig D (2004) Antologous serum eyedrops for ocular surface disorders. Br J Ophthalmol 88:1467–1474

    Article  CAS  PubMed  Google Scholar 

  54. Schrader S, Wedel T, Moll R, Geerling G (2005) Use of a combination of serum eyedrops and hydrogel bandage contact lens for persistent epithelial defects. DOG-abstract, 2609-14.01

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Würzburg, Josef-Schneider-Strasse 11, 97080, Würzburg, Germany

    Gerd Geerling (Prof. Dr.)

  2. Institute of Immunology and Transfusion Medicine, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany

    Dirk Hartwig (Dr.)

Authors
  1. Gerd Geerling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dirk Hartwig
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University Eye Hospital, Killianstrasse 5, 79106, Freiburg, Germany

    Thomas Reinhard MD (Professor of Ophthalmology) (Professor of Ophthalmology)

  2. Cornea & External Diseases Service, Moorfields Eye Hospital, London, EC1V 2PD, UK

    D.F.P. Larkin MD, MRCPF, FRCS

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Geerling, G., Hartwig, D. (2006). Autologous Serum Eyedrops for Ocular Surface Disorders. In: Reinhard, T., Larkin, D. (eds) Cornea and External Eye Disease. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31226-9_1

Download citation

  • DOI: https://doi.org/10.1007/3-540-31226-9_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22600-0

  • Online ISBN: 978-3-540-31226-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation